Clinical and Experimental Effectiveness of Astragali Compound in the Treatment of Chronic Viral Hepatitis B

Author： Tang LL   Sheng JF   Xu CH   Liu KZ  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.3, 2009-05, pp. : 662-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines

By Siebert Uwe   Sroczynski Gaby   Aidelsburger Pamela  

PharmacoEconomics, Vol. 27, Iss. 4, 2009-06 ,pp. : 341-354

Adis International

Access to resources Recommend Favorite

Agents in clinical development for the treatment of chronic hepatitis B

By Raney Anneke K   Hamatake Robert K   Hong Zhi  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1281-1295

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B

By Crowley S.J.  

PharmacoEconomics, Vol. 17, Iss. 5, 2000-05 ,pp. : 409-427

Adis International

Access to resources Recommend Favorite

Treatment of Chronic Hepatitis B

By  

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 953-958

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of viral hepatitis B in children

By Giacchino Raffaella   Cappelli Barbara  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 889-903

Informa Healthcare

Access to resources Recommend Favorite